Table 3 Summary of QA feedback
From: Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy
Topic | Percentage of benchmark cases requiring feedback | Percentage of on-trial cases requiring feedback |
|---|---|---|
Outlining of GTV | 72% | N/A |
Target margins | 39% | 16% |
Outlining of OARs | 50% | 64% |
Cord PRV margin | 33% | 36% |
Treatment Plan | 22% | 10% |
Completion of the PAF | 69% | 42% |